Benzinga | May 10, 2021 04:03PM EDT

FibroGen Q1 EPS $(0.78) Beats $(0.87) Estimate, Sales $38.40M Miss $41.79M Estimate

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.87) by 10.34 percent. This is a 12.36 percent increase over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $38.40 million which missed the analyst consensus estimate of $41.79 million by 8.11 percent. This is a 57.37 percent increase over sales of $24.40 million the same period last year.